NewAmsterdam Pharma Company
NAMS
#4459
Rank
NZ$3.19 B
Marketcap
$34.60
Share price
0.40%
Change (1 day)
110.68%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.10 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are NZ$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$92.82 M13.45%
2022-12-31NZ$81.82 M336.27%
2021-12-31NZ$18.75 M-30.16%
2020-12-31NZ$26.85 M